.
.
.
Manufacturing & Scale-Up for Generic Drugs
At ResolveMass Laboratories Inc., our Manufacturing & Scale-Up for Generic Drugs services are designed to bridge the critical gap between research and full commercial production. We specialize in transitioning pharmaceutical products from pilot batches to large-scale manufacturing while ensuring strict adherence to global GMP standards. With a deep understanding of regulatory expectations, process optimization, and quality assurance, our team ensures your generic drug products reach the market efficiently, safely, and compliantly.
From early-stage formulation to commercial readiness, we offer end-to-end solutions that minimize risks, reduce timelines, and enhance reproducibility—helping pharmaceutical companies scale with confidence.
Share via:
Comprehensive Manufacturing & Scale-Up Solutions
- Process Development & Optimization
We refine manufacturing processes to ensure scalability without compromising product quality. Our approach includes parameter optimization, robustness testing, and technology transfer readiness.
Ensure your formulation remains stable throughout the scale-up process with our Stability Studies for Pharma.
- Pilot Batch Manufacturing
Our pilot-scale facilities enable accurate simulation of large-scale production, allowing identification of potential challenges early in the development lifecycle.
Validate your molecular structures during pilot phases using high-precision NMR Services.
- Commercial Scale-Up
We ensure smooth scale-up from pilot batches to full production volumes, maintaining consistency, yield, and regulatory compliance throughout the process.
Maintain high-purity standards during large-scale production with expert Residual Solvent Testing.
- GMP-Compliant Manufacturing
All operations strictly follow current Good Manufacturing Practices (cGMP), ensuring product safety, traceability, and regulatory acceptance across global markets.
Transitioning from Pilot to Commercial Manufacturing
One of the most critical stages in pharmaceutical development is transitioning from pilot batches to large-scale commercial manufacturing while maintaining strict GMP compliance. At ResolveMass Laboratories Inc., we apply a science-driven and data-backed approach to scale-up, ensuring that process parameters remain consistent across different production volumes.
Streamline your transition with rigorous Analytical Method Development and Validation Services.
We conduct detailed risk assessments, process validation, and analytical verification to guarantee that product quality attributes are preserved during scale-up. Our expertise minimizes variability, ensures batch-to-batch consistency, and accelerates regulatory approvals—making us a trusted partner in generic drug commercialization.
Detect potential impurities at the parts-per-billion level using High-Resolution Mass Spectrometry (HRMS) Analysis.
Why Partner with ResolveMass Laboratories Inc.?
- Proven experience in generic drug manufacturing and scale-up
- Strong adherence to global GMP and regulatory standards A
- dvanced analytical and process validation capabilities
- End-to-end support from development to commercialization
- Focus on quality, reproducibility, and compliance
- Dedicated team of pharmaceutical scientists and engineers
Assess the safety of your packaging and container closures with Extractables and Leachables Testing.
Our Proven Scale-Up Workflow
- Initial process evaluation and feasibility study
- Pilot batch development and optimization
- Risk assessment and process validation
- Scale-up execution and monitoring
- GMP-compliant commercial manufacturing
- Continuous quality improvement and regulatory support
Ensure complex generics meet regulatory expectations with our Peptide Characterization Services.
Built on Scientific Excellence and Regulatory Confidence
ResolveMass Laboratories Inc. operates with a commitment to scientific integrity, regulatory precision, and operational excellence. Our team combines deep industry experience with cutting-edge technologies to deliver reliable and scalable manufacturing solutions. By maintaining transparent processes, validated methodologies, and strict compliance protocols, we ensure that every product meets the highest standards of safety and efficacy.
Accelerate Your Success with Expert Manufacturing & Scale-Up
Choosing the right partner for Manufacturing & Scale-Up for Generic Drugs can significantly impact your product’s success in the market. ResolveMass Laboratories Inc. combines technical expertise, regulatory knowledge, and advanced infrastructure to deliver scalable, compliant, and high-quality manufacturing solutions. Whether you are moving from pilot batches or preparing for full commercialization, we are here to support every step of your journey.
Frequently Asked Questions (FAQs)
Scale-up is essential because a formulation that works in small batches may behave differently in large production. It ensures that the drug maintains its consistency, effectiveness, and stability when produced in bulk. Without proper scale-up, regulatory approval can be delayed.
During scale-up, issues such as inconsistent mixing, heat transfer differences, and equipment variation can arise. These factors may affect the final product quality if not carefully managed. Proper planning, testing, and validation help minimize these risks.
GMP compliance is maintained by following strict procedures, documentation practices, and quality control checks throughout production. Every step is monitored to ensure it meets regulatory standards. This helps guarantee product safety and reliability.
Consistency is achieved by controlling critical process parameters and using validated manufacturing methods. Regular quality testing and in-process monitoring help detect any deviations early. This ensures each batch meets the same specifications.
Pilot batches act as a bridge between laboratory development and full-scale manufacturing. They allow manufacturers to test processes under conditions similar to commercial production. This helps identify and fix potential issues before scaling up.
Process validation confirms that the manufacturing method consistently produces a product that meets quality standards. It involves testing and documenting each step of production. This is a key requirement for regulatory approval and long-term reliability.
Reference:
- Joshi, S. S. (2019). Generic drugs: The Indian scenario. Perspectives in Clinical Research, 10(2), 72–77. https://doi.org/10.4103/picr.PICR_123_18
- Suresh, K., Mehta, T., Thakrar, V., & Sharma, R. G. (2025). Innovative strategies in generic drug development: The role of polymorph, amorphous, pseudopolymorph, and cocrystal solid forms. Crystal Growth & Design, 25(4), 1282–1292. https://doi.org/10.1021/acs.cgd.4c01558
- Kesselheim, A. S., Misono, A. S., Lee, J. L., Stedman, M. R., Brookhart, M. A., Choudhry, N. K., & Shrank, W. H. (2008). Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: A systematic review and meta-analysis. JAMA, 300(21), 2514–2526. https://doi.org/10.1001/jama.2008.758